Company: LGN
Filing Date: 2025-08-15
Form Type: S-1
Source: 0001193125-25-181698
Chunk: 269

Company: Legence Corp.
Filing Date: 2025-08-15
Form: S-1
Chunk 269
---
         |   |
|:-------------------------------------------------------------------------------------------------|:----|:------------------------|--------:|:--|:----|:-----|--------:|:--|:----|:-----|--------:|:--|
|                                                                                                  |     | -Dollars in thousands   |         |   |     |      |         |   |     |      |         |   |
| Debt issuance costs                                                                              |     |                         |  (1,495 | ) |     |      |  (3,499 | ) |     |      |  (3,982 | ) |
| Payments for deferred offering costs                                                             |     |                         |    (196 | ) |     |      |       — |   |     |      |       — |   |
| Payments of contingent consideration (including ($20,663), ($5,520) and ($1,900) for years ended 
 December 31, 2024, 2023 and 2022, respectively, from related parties)                            |     |                         | (32,504 | ) |     |      |  (5,520 | ) |     |      |  (1,900 | ) |
| Cash provided by financing activities                                                            |     |                         | 206,964 |   |     |      | 128,471 |   |     |      | 173,807 |   |
| (Decrease) increase in cash and cash equivalents and restricted cash                             |     |                         |  (7,753 | ) |     |      |  28,486 |   |     |      |  40,428 |   |
| Cash and cash equivalents and restricted cash, beginning of period                               |     |                         |  88,920 |   |     |      |  60,434 |   |     | $    |  20,006 |   |
| Cash and cash equivalents and restricted cash, end of period                                     |     | $                       |  81,167 |   |     | $    |  88,920 |   |     | $    |  60,434 |   |

The supplemental disclosures to the Consolidated Statements of Cash Flows are included in “ Note 19—Other Financial Information” See Notes to Consolidated Financial Statements. F-15

Legence Holdings LLC and Subsidiaries

Notes to Consolidated Financial Statements

Note 1—Nature of Operations

Legence Holdings LLC
and its subsidiaries (“Leg